Contributing to the fight against the novel coronavirus epidemic.
The recent novel coronavirus epidemic has spurred socially responsible companies into action. Having already made two donations to designated medical institutions on January 23 and 29, leading appliance maker Galanz announced on February 1 a donation of appliances RMB¥100 million, to support medical and auxiliary staff on the front line of the coronavirus epidemic.
As China’s top microwave oven brand, Galanz is renowned not only for its first-class products and services but also for its corporate social responsibility. In past years, Galanz has contributed to social welfare by promoting food safety, epidemic prevention, sterilization and disinfection through a broad portfolio of patented technologies and products.
Developed in 2001, the patented Galanz LightWave is capable of highly efficient sterilization and disinfection. Based on independent laboratory reports, the Galanz LightWave oven has a 100% sterilization rate of Salmonella, Escherichia coli, Staphylococcus Albicans, Candida albicans, Pseudomonas aeruginosa, Staphylococcus Aureus, and other bacteria. The Galanz LightWave oven can facilitate daily sterilization and disinfection, as well as contribute towards a healthy cooking lifestyle. Since the launch of the Galanz LightWave oven, it has played an important role in mitigating the 2003 SARS epidemic, the 2004 Indian Ocean Tsunami, H5N1 influenza, and other public health crises.
Immediately after the outbreak of the novel coronavirus epidemic, Galanz immediately assigned local staff in Wuhan to donate appliances to local medical institutions, including Wuhan Union Medical College Hospital and Wuhan Tongji Hospital. Galanz was the first appliance company to make donations in the novel coronavirus epidemic.
“Galanz is a Chinese company. Whenever the situation calls upon us, Galanz will press ahead with decisive action.” said Leung Chiu Yin, Chairman and President of Galanz, “In this critical juncture, we could surmount all challenges and defeat the novel coronavirus epidemic.”